Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Mar 7, 2017; 23(9): 1645-1656
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1645
Table 3 Results of the technical and clinical success rates for each parameter
ParametersTotal patients (n = 58)
Technical success rateClinical success rate
Indications
Refractory bleeding88.9 (16/18)83.3 (15/18)
Leak89.3 (25/28)85.7 (24/28)
Fistula91.7 (11/12)83.3 (10/12)
Location
Upper GI tract86.4(38/44)81.8 (36/44)
Lower GI tract100 (14/14)92.9 (13/14)
Maximum defect size (D), mm
D ≤ 1096 (24/25)84 (21/25)
10 < D ≤ 2088.9 (8/9)88.9 (8/9)
20 < D83.3 (20/24)83.3 (20/24)
Duration since onset, % (n)
Immediate ≤ 1 d96 (24/25)96 (24/25)
1 < Acute ≤ 7 d90.9 (10/11)81.8 (9/11)
Chronic > 7 d81.8 (18/22)72.7 (16/22)
Suction method into the applicator cap
Simple suction (SS)100 (14/14)78.6 (11/14)
Twin Grasper (TG) Anchor assist88.1 (37/42) 50 (1/2)88.1 (37/42) 50 (1/2)
The number of OTSC deployments, n
192.3 (36/39)84.6 (33/39)
2100 (12/12)100 (12/12)
380 (4/5)80 (4/5)